Researchers from Helmholtz Munich and the Technical University of Munich have developed a novel method to track cancer treatment responses in individual cells—without the need for dyes or labels.

Take a closer look at the radiopharma new wave as Nuclidium and Actithera raise big to develop their platforms.

Young patient's journey with thyroid disorder, radioactive iodine treatment, and importance of iodine in the body.

Meet 12 biotech companies with promising genetic disease therapies that successfully closed funding rounds recently.

Scientists discover zebrafish hair cells can regenerate without cell division, challenging decades of textbook biology and ...

Primo Biotechnology Co., Ltd., a pioneering radiopharmaceutical company in Taiwan, announced the successful completion of its NT$220 million Series A funding round. With total capital raised now ...

Identifying the correct uveitis type can help reveal underlying systemic infections, neoplastic conditions, and other ...

Lantheus ( ($LNTH) ) has issued an update. On July 21, 2025, Lantheus completed its acquisition of Life Molecular Imaging Limited, enhancing its ...

In a scientific first, researchers from Vanderbilt University and the University of California, San Diego, have generated a high-resolution metabolic "map" of how cells orchestrate glucose processing, ...

One of ANSTO's advanced imaging instruments Dingo now delivers a rare fusion of simulation and radiobiology, becoming a ...

In a new study, researchers show, for the first time, that photoacoustic microscopy can image stents through skin, ...